The occurrence of kidney cancer has increased in the recent years. Excessive smoking, rise in obesity because of sedentary life routines and increased consumption of alcohol are some of the causes of kidney cancer. The most common type of cancer is Renal Cell Carcinoma (RCC).Immunotherapies or targeted therapies are the most common prescribed treatments for kidney cancer.

Market Analysis and Insights: Global Kidney Cancer Therapeutics and Diagnostics Market

The global Kidney Cancer Therapeutics and Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Kidney Cancer Therapeutics and Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Kidney Cancer Therapeutics and Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Kidney Cancer Therapeutics and Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Kidney Cancer Therapeutics and Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Kidney Cancer Therapeutics and Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Kidney Cancer Therapeutics and Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Kidney Cancer Therapeutics and Diagnostics Market Report

Report Metric	Details
Report Name	Kidney Cancer Therapeutics and Diagnostics Market
CAGR	5%
Segment by Type	Cystoscopy Biopsy Intravenous Pyelogram CT Scan Kidney Ultrasound Others
Segment by Application	Hospitals Pharmaceutical Labs Genomics Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Hoffmann La Roche, GlaxoSmithKline, Novartis, Pfizer, Abbott Laboratories, Amgen, Genentech, Cerulean Pharma, Seattle Genetics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Kidney Cancer Therapeutics and Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney Cancer Therapeutics and Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Kidney Cancer Therapeutics and Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Kidney Cancer Therapeutics and Diagnostics Market report?

Ans: The main players in the Kidney Cancer Therapeutics and Diagnostics Market are Bayer, Hoffmann La Roche, GlaxoSmithKline, Novartis, Pfizer, Abbott Laboratories, Amgen, Genentech, Cerulean Pharma, Seattle Genetics

What are the Application segmentation covered in the Kidney Cancer Therapeutics and Diagnostics Market report?

Ans: The Applications covered in the Kidney Cancer Therapeutics and Diagnostics Market report are Hospitals, Pharmaceutical Labs, Genomics Laboratories, Others

What are the Type segmentation covered in the Kidney Cancer Therapeutics and Diagnostics Market report?

Ans: The Types covered in the Kidney Cancer Therapeutics and Diagnostics Market report are Cystoscopy, Biopsy, Intravenous Pyelogram, CT Scan, Kidney Ultrasound, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Cystoscopy

1.2.3 Biopsy

1.2.4 Intravenous Pyelogram

1.2.5 CT Scan

1.2.6 Kidney Ultrasound

1.2.7 Others

1.3 Market by Application

1.3.1 Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Pharmaceutical Labs

1.3.4 Genomics Laboratories

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Kidney Cancer Therapeutics and Diagnostics Market Perspective (2019-2030)

2.2 Global Kidney Cancer Therapeutics and Diagnostics Growth Trends by Region

2.2.1 Kidney Cancer Therapeutics and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Kidney Cancer Therapeutics and Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Kidney Cancer Therapeutics and Diagnostics Market Dynamics

2.3.1 Kidney Cancer Therapeutics and Diagnostics Industry Trends

2.3.2 Kidney Cancer Therapeutics and Diagnostics Market Drivers

2.3.3 Kidney Cancer Therapeutics and Diagnostics Market Challenges

2.3.4 Kidney Cancer Therapeutics and Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Kidney Cancer Therapeutics and Diagnostics by Players

3.1.1 Global Kidney Cancer Therapeutics and Diagnostics Revenue by Players (2019-2024)

3.1.2 Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Kidney Cancer Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Kidney Cancer Therapeutics and Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Kidney Cancer Therapeutics and Diagnostics Market Concentration Ratio

3.4.1 Global Kidney Cancer Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Therapeutics and Diagnostics Revenue in 2023

3.5 Global Key Players of Kidney Cancer Therapeutics and Diagnostics Head office and Area Served

3.6 Global Key Players of Kidney Cancer Therapeutics and Diagnostics, Product and Application

3.7 Global Key Players of Kidney Cancer Therapeutics and Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Kidney Cancer Therapeutics and Diagnostics Breakdown Data by Type

4.1 Global Kidney Cancer Therapeutics and Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030)

5 Kidney Cancer Therapeutics and Diagnostics Breakdown Data by Application

5.1 Global Kidney Cancer Therapeutics and Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size (2019-2030)

6.2 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type

6.2.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2019-2024)

6.2.2 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2025-2030)

6.2.3 North America Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2019-2030)

6.3 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application

6.3.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2019-2024)

6.3.2 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2025-2030)

6.3.3 North America Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2019-2030)

6.4 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country

6.4.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2019-2024)

6.4.3 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size (2019-2030)

7.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type

7.2.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2019-2024)

7.2.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2025-2030)

7.2.3 Europe Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2019-2030)

7.3 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application

7.3.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2019-2024)

7.3.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2025-2030)

7.3.3 Europe Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2019-2030)

7.4 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country

7.4.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2019-2024)

7.4.3 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Kidney Cancer Therapeutics and Diagnostics Market Size (2019-2030)

8.2 China Kidney Cancer Therapeutics and Diagnostics Market Size by Type

8.2.1 China Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2019-2024)

8.2.2 China Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2025-2030)

8.2.3 China Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2019-2030)

8.3 China Kidney Cancer Therapeutics and Diagnostics Market Size by Application

8.3.1 China Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2019-2024)

8.3.2 China Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2025-2030)

8.3.3 China Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Kidney Cancer Therapeutics and Diagnostics Market Size (2019-2030)

9.2 Asia Kidney Cancer Therapeutics and Diagnostics Market Size by Type

9.2.1 Asia Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2019-2024)

9.2.2 Asia Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2025-2030)

9.2.3 Asia Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2019-2030)

9.3 Asia Kidney Cancer Therapeutics and Diagnostics Market Size by Application

9.3.1 Asia Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2019-2024)

9.3.2 Asia Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2025-2030)

9.3.3 Asia Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2019-2030)

9.4 Asia Kidney Cancer Therapeutics and Diagnostics Market Size by Region

9.4.1 Asia Kidney Cancer Therapeutics and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2019-2024)

9.4.3 Asia Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Details

11.1.2 Bayer Business Overview

11.1.3 Bayer Kidney Cancer Therapeutics and Diagnostics Introduction

11.1.4 Bayer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

11.1.5 Bayer Recent Developments

11.2 Hoffmann La Roche

11.2.1 Hoffmann La Roche Company Details

11.2.2 Hoffmann La Roche Business Overview

11.2.3 Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Introduction

11.2.4 Hoffmann La Roche Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

11.2.5 Hoffmann La Roche Recent Developments

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Details

11.3.2 GlaxoSmithKline Business Overview

11.3.3 GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Introduction

11.3.4 GlaxoSmithKline Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

11.3.5 GlaxoSmithKline Recent Developments

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Kidney Cancer Therapeutics and Diagnostics Introduction

11.4.4 Novartis Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

11.4.5 Novartis Recent Developments

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Kidney Cancer Therapeutics and Diagnostics Introduction

11.5.4 Pfizer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

11.5.5 Pfizer Recent Developments

11.6 Abbott Laboratories

11.6.1 Abbott Laboratories Company Details

11.6.2 Abbott Laboratories Business Overview

11.6.3 Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Introduction

11.6.4 Abbott Laboratories Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

11.6.5 Abbott Laboratories Recent Developments

11.7 Amgen

11.7.1 Amgen Company Details

11.7.2 Amgen Business Overview

11.7.3 Amgen Kidney Cancer Therapeutics and Diagnostics Introduction

11.7.4 Amgen Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

11.7.5 Amgen Recent Developments

11.8 Genentech

11.8.1 Genentech Company Details

11.8.2 Genentech Business Overview

11.8.3 Genentech Kidney Cancer Therapeutics and Diagnostics Introduction

11.8.4 Genentech Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

11.8.5 Genentech Recent Developments

11.9 Cerulean Pharma

11.9.1 Cerulean Pharma Company Details

11.9.2 Cerulean Pharma Business Overview

11.9.3 Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Introduction

11.9.4 Cerulean Pharma Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

11.9.5 Cerulean Pharma Recent Developments

11.10 Seattle Genetics

11.10.1 Seattle Genetics Company Details

11.10.2 Seattle Genetics Business Overview

11.10.3 Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Introduction

11.10.4 Seattle Genetics Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

11.10.5 Seattle Genetics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Cystoscopy

Table 3. Key Players of Biopsy

Table 4. Key Players of Intravenous Pyelogram

Table 5. Key Players of CT Scan

Table 6. Key Players of Kidney Ultrasound

Table 7. Key Players of Others

Table 8. Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 9. Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Region (2019-2024)

Table 12. Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Region (2025-2030)

Table 14. Kidney Cancer Therapeutics and Diagnostics Market Trends

Table 15. Kidney Cancer Therapeutics and Diagnostics Market Drivers

Table 16. Kidney Cancer Therapeutics and Diagnostics Market Challenges

Table 17. Kidney Cancer Therapeutics and Diagnostics Market Restraints

Table 18. Global Kidney Cancer Therapeutics and Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Kidney Cancer Therapeutics and Diagnostics Revenue Share by Players (2019-2024)

Table 20. Global Top Kidney Cancer Therapeutics and Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Therapeutics and Diagnostics as of 2023)

Table 21. Global Kidney Cancer Therapeutics and Diagnostics Industry Ranking 2022 VS 2023 VS 2024

Table 22. Global 5 Largest Players Market Share by Kidney Cancer Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 23. Global Key Players of Kidney Cancer Therapeutics and Diagnostics, Headquarters and Area Served

Table 24. Global Key Players of Kidney Cancer Therapeutics and Diagnostics, Product and Application

Table 25. Global Key Players of Kidney Cancer Therapeutics and Diagnostics, Product and Application

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Type (2019-2024)

Table 29. Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Type (2025-2030)

Table 31. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Kidney Cancer Therapeutics and Diagnostics Revenue Share by Application (2019-2024)

Table 33. Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Kidney Cancer Therapeutics and Diagnostics Revenue Share by Application (2025-2030)

Table 35. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 36. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 37. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 38. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 39. North America Kidney Cancer Therapeutics and Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 41. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 42. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 43. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 44. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 45. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 46. Europe Kidney Cancer Therapeutics and Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 48. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 49. China Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 50. China Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 51. China Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 52. China Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 54. Asia Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 55. Asia Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 56. Asia Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 57. Asia Kidney Cancer Therapeutics and Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 58. Asia Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 59. Asia Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 65. Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 66. Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 67. Bayer Company Details

Table 68. Bayer Business Overview

Table 69. Bayer Kidney Cancer Therapeutics and Diagnostics Product

Table 70. Bayer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 71. Bayer Recent Developments

Table 72. Hoffmann La Roche Company Details

Table 73. Hoffmann La Roche Business Overview

Table 74. Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Product

Table 75. Hoffmann La Roche Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 76. Hoffmann La Roche Recent Developments

Table 77. GlaxoSmithKline Company Details

Table 78. GlaxoSmithKline Business Overview

Table 79. GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Product

Table 80. GlaxoSmithKline Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 81. GlaxoSmithKline Recent Developments

Table 82. Novartis Company Details

Table 83. Novartis Business Overview

Table 84. Novartis Kidney Cancer Therapeutics and Diagnostics Product

Table 85. Novartis Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 86. Novartis Recent Developments

Table 87. Pfizer Company Details

Table 88. Pfizer Business Overview

Table 89. Pfizer Kidney Cancer Therapeutics and Diagnostics Product

Table 90. Pfizer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 91. Pfizer Recent Developments

Table 92. Abbott Laboratories Company Details

Table 93. Abbott Laboratories Business Overview

Table 94. Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Product

Table 95. Abbott Laboratories Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 96. Abbott Laboratories Recent Developments

Table 97. Amgen Company Details

Table 98. Amgen Business Overview

Table 99. Amgen Kidney Cancer Therapeutics and Diagnostics Product

Table 100. Amgen Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 101. Amgen Recent Developments

Table 102. Genentech Company Details

Table 103. Genentech Business Overview

Table 104. Genentech Kidney Cancer Therapeutics and Diagnostics Product

Table 105. Genentech Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 106. Genentech Recent Developments

Table 107. Cerulean Pharma Company Details

Table 108. Cerulean Pharma Business Overview

Table 109. Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Product

Table 110. Cerulean Pharma Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 111. Cerulean Pharma Recent Developments

Table 112. Seattle Genetics Company Details

Table 113. Seattle Genetics Business Overview

Table 114. Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Product

Table 115. Seattle Genetics Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 116. Seattle Genetics Recent Developments

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. Cystoscopy Features

Figure 4. Biopsy Features

Figure 5. Intravenous Pyelogram Features

Figure 6. CT Scan Features

Figure 7. Kidney Ultrasound Features

Figure 8. Others Features

Figure 9. Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 10. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Application: 2023 VS 2030

Figure 11. Hospitals Case Studies

Figure 12. Pharmaceutical Labs Case Studies

Figure 13. Genomics Laboratories Case Studies

Figure 14. Others Case Studies

Figure 15. Kidney Cancer Therapeutics and Diagnostics Report Years Considered

Figure 16. Global Kidney Cancer Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Kidney Cancer Therapeutics and Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Region: 2023 VS 2030

Figure 19. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Players in 2023

Figure 20. Global Top Kidney Cancer Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Therapeutics and Diagnostics as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Kidney Cancer Therapeutics and Diagnostics Revenue in 2023

Figure 22. North America Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2019-2030)

Figure 24. North America Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2019-2030)

Figure 25. North America Kidney Cancer Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 26. United States Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Kidney Cancer Therapeutics and Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 29. Europe Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2019-2030)

Figure 30. Europe Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2019-2030)

Figure 31. Europe Kidney Cancer Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 32. Germany Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. France Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. U.K. Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Italy Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Russia Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Nordic Countries Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. China Kidney Cancer Therapeutics and Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 39. China Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2019-2030)

Figure 40. China Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2019-2030)

Figure 41. Asia Kidney Cancer Therapeutics and Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 42. Asia Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2019-2030)

Figure 43. Asia Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2019-2030)

Figure 44. Asia Kidney Cancer Therapeutics and Diagnostics Market Share by Region (2019-2030)

Figure 45. Japan Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. South Korea Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. China Taiwan Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Southeast Asia Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. India Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Australia Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 52. Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2019-2030)

Figure 53. Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2019-2030)

Figure 54. Middle East, Africa, and Latin America Kidney Cancer Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 55. Brazil Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Mexico Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Turkey Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Saudi Arabia Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Israel Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. GCC Countries Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. Bayer Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

Figure 62. Hoffmann La Roche Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

Figure 63. GlaxoSmithKline Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

Figure 64. Novartis Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

Figure 65. Pfizer Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

Figure 66. Abbott Laboratories Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

Figure 67. Amgen Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

Figure 68. Genentech Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

Figure 69. Cerulean Pharma Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

Figure 70. Seattle Genetics Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Exosome Medical Technology Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14U12944

Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Tumor Marker Detection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5A12294

Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Hematological Malignancy Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15J11325

Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Personalized Cancer Medicine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11F3068

Fri Mar 07 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions